Diabetic onychomycosis treatment — the specialized care for 25-50% of diabetic patients developing nail fungus, with 3-5x higher infection risk and complications including cellulitis and foot ulcers representing the fastest-growing patient segment in topical antifungal therapy — creates the most clinically critical market category, with the Amorolfine Hydrochloride Liniment Market...